Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD
Abstract Background Current therapy for patients suffering from inflammatory bowel diseases (IBD) is focused on inflammatory mechanisms exclusively and not the dysbiotic microbiota, despite growing evidence implicating a role for intestinal microbes in disease. Main body Ongoing research into the in...
Saved in:
Main Author: | Paul F. Miller (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IBD Management - Novel Targets and Therapeutic Perspectives
Published: (2020) -
Editorial: IBD Management-Novel Targets and Therapeutic Perspectives
by: Luca Antonioli, et al.
Published: (2020) -
Oligonucleotides-A Novel Promising Therapeutic Option for IBD
by: Patrizio Scarozza, et al.
Published: (2019) -
Hsp60 as a Novel Target in IBD Management: A Prospect
by: Francesco Cappello, et al.
Published: (2019) -
Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD
by: Andrea Grandi, et al.
Published: (2019)